Beyond the Definitions of the Phenotypic Complications of Sickle Cell Disease: An Update on Management
The sickle hemoglobin is an abnormal hemoglobin due to point mutation (GAG → GTG) in exon 1 of the β globin gene resulting in the substitution of glutamic acid by valine at position 6 of the β globin polypeptide chain. Although the molecular lesion is a single-point mutation, the sickle gene is plei...
Saved in:
Main Authors: | Samir K. Ballas, Muge R. Kesen, Morton F. Goldberg, Gerard A. Lutty, Carlton Dampier, Ifeyinwa Osunkwo, Winfred C. Wang, Carolyn Hoppe, Ward Hagar, Deepika S. Darbari, Punam Malik |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/2012/949535 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Erratum to “Beyond the Definitions of the Phenotypic Complications of Sickle Cell Disease: An Update on Management”
by: Samir K. Ballas, et al.
Published: (2013-01-01) -
Morphine for the Treatment of Pain in Sickle Cell Disease
by: Mihir Gupta, et al.
Published: (2015-01-01) -
Genetic Correction of Sickle Cell Anemia and β-Thalassemia: Progress and New Perspective
by: Ajay Perumbeti, et al.
Published: (2010-01-01) -
Elevated Circulating Angiogenic Progenitors and White Blood Cells Are Associated with Hypoxia-Inducible Angiogenic Growth Factors in Children with Sickle Cell Disease
by: Solomon F. Ofori-Acquah, et al.
Published: (2012-01-01) -
The Validation of the sickle scan technique used to diagnose sickle cell disease
by: Magain Mihatano Barihuta, et al.
Published: (2025-01-01)